Kristof Van Emelen

Company: Obulytix

Job title: Chief Executive Officer

Seminars:

Developing Engineered Lysin Proteins to Combat Antibiotic-Resistant Bacteria 3:45 pm

Using DNA shuffling technology for recombinant assembly of high dimensional libraries of engineered lysins Integrating high-throughput production and screening of lysins active against gramnegative bacteria Maintaing activity of lysins under physiological conditions New Company!Read more

day: Conference Day Two